TRV GP IV, LLC's Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Sep 17, 2024
- Accession no.
- 0000950170-24-107330
- Filed
- Sep 17, 2024, 4:48 PM ET
- Trade date
- Sep 13, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $709.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TRV GP IV, LLCCIK 0001688325 | 10% Owner |
| Third Rock Ventures GP IV, L.P.CIK 0001688326 | 10% Owner |
| Third Rock Ventures IV, L.P.CIK 0001688327 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Common Stock | SSaleDisposed | −67,400 | $10.53 | −$709,755.7 | 16,859,075 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.